Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
New words:
accumulation, adaptive, addressed, ADHD, adjustment, advertising, advisory, airway, allergy, amlodipine, AMOBAN, andNEOCLARITYN, angina, animal, antagonist, API, bioavailable, Bioscience, bladder, bronchoconstriction, calcium, candidate, cardiomyopathy, centered, Chase, CIU, CLARINEX, Click, closest, constant, constipation, COPD, CORD, deal, debate, Defense, Deutsche, diabetic, dispensing, driven, earn, earned, edema, electrical, enacted, entity, esophageal, esopiclone, ESTORRA, eszopiclone, face, female, gastro, governmental, great, HFA, hired, HMSR, hospital, hypertension, hypnotic, idiopathic, impulse, interval, JP, kinetic, Leasehold, Lien, light, LLC, male, Manhattan, MDI, Medicaid, Medicare, merger, metered, micturition, Mining, Minnesota, molecular, mortgage, muscle, Nashville, navigate, NORVASC, obstructive, opiate, overactive, panel, pantroprazole, pathologic, percent, perennial, peripheral, pharmacist, pharmacodynamic, pharmacokinetic, pharmacy, Plough, Point, popular, PositionTimothy, prescribed, prolongation, prolonged, Provision, pseudoephedrine, pulmonary, quantify, recommendation, recommended, reimburse, reimbursement, retail, return, Robertson, Rule, schizophrenia, sheet, ship, smaller, statutorily, storage, strong, substitute, surgery, suspended, suspending, swelling, synthesize, tecastemizole, Tennessee, TID, tissue, transient, Trust, uncertainty, unknown, unmet, unrelated, unused, upcoming, utilizing, variability, Veteran, Waterford, XUSAL, XYZAL, Zithromax
Removed:
accessibility, acid, affinity, alleged, applied, benign, biopharmaceutical, broadening, cardiac, cetirizine, code, commercializing, complaint, complex, Confidential, consisting, contracted, controlled, declaratory, decrease, defend, delay, description, difficulty, District, doctor, doxazosin, effort, eliminate, enlargement, estimated, expiring, factual, fainting, fee, gastric, gastroesophageal, half, high, HMRI, Home, hyperplasia, hypotension, impact, improvement, infringe, infringement, invested, judgment, leveraging, licensing, lowering, membrane, opportunity, orthostatic, outlicensing, pantoprazole, participate, patented, preferred, pressure, prevacid, prostate, prostatic, protect, pump, purer, purpose, rate, Receivable, reduction, resource, risk, safer, showed, specialty, spherical, strategic, suggested, TAP, technical, throughput, trade, ultra, unwanted, uterine, validity, vitro, vivo, widespread
Filing tables
Filing exhibits
SEPR similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Exhibit 23.2
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the use of our report dated January 17, 2001 on the financial statements of BioSphere Medical, Inc. and subsidiaries as of December 31, 1999 and 2000 and for each of the two years in the period ended December 31, 2000, included in this Form 10-K.
/s/ ARTHUR ANDERSEN LLP
Boston, Massachusetts
March 28, 2002
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS